Log in to save to my catalogue

CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subject...

CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subject...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9f97748ebdd141d68a0c2fd8d848179a

CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

About this item

Full title

CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2021-12, Vol.23 (1), p.306-306, Article 306

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In rheumatoid arthritis (RA), macrophages play an important role in modulating the immunoinflammatory response through their polarisation into "classically" (M1) or "alternatively activated" (M2) phenotypes. In RA, CTLA4-Ig (abatacept) reduces the inflammatory activity of macrophages by interacting with the costimulatory molecule CD86. The study ai...

Alternative Titles

Full title

CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9f97748ebdd141d68a0c2fd8d848179a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9f97748ebdd141d68a0c2fd8d848179a

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-021-02691-9

How to access this item